PREVENÇÃO E TRATAMENTO DAS MUCOSITES ORAIS: UMA REVISÃO SISTEMÁTICA
DOI :
https://doi.org/10.13102/rscdauefs.v6i2.1189Mots-clés :
Mucosite Oral, Radioterapia, Quimioterapia, Neoplasias de Cabeça e Pescoço.Résumé
A proposta deste estudo foi realizar uma revisão sistemática da literatura, sobre mucosite oral (MO) em pacientes submetidos à radioterapia e quimioterapia para tratamento de tumores na região de cabeça e pescoço, de modo a levantar evidências científicas sobre prevenção e tratamento destas complicações. Os procedimentos metodológicos foram baseados nas recomendações da Cochrane Collaboration. Após a realização da busca nas bases de dados, obteve-se 3203 artigos, destes, 22 foram selecionados. Sete reportaram a terapia com Laser, três artigos avaliaram o uso do Mel, dois sobre o uso de Palifermin®, além de estudos sobre o Actovegin® endovenoso, enxaguatórios bucais a base de calêndula, fenilbutirato, clorexidina e cloreto de cetil-piridino. Outros abordaram o uso da radioterapia pela manhã, a crioterapia, o suco de aloe vera, o papel do Lactobacillus Brevis, do maleato de irsogladina e do fator de crescimento epidérmico. Os resultados obtidos nesta investigação apontam que a terapia com laser de baixa potência ainda é a mais indicada na prevenção e tratamento da mucosite oral. Entretanto, ainda é necessária a continuidade dos estudos que visam responder à temática, visto que, quanto maior for o esforço nessa área, maiores serão as chances de reduzir o número de indivíduos acometidos pela MO.
Téléchargements
Métriques
Références
Rahal P, Colombo J. Alterações genéticas em câncer de cabeça e pescoço. Rev. bras. cancerol. 2009; 55(2): 165-174.
Dobrossy L. Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 2005;24: 9-17.
Brasil. Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2014: incidência de câncer no Brasil. Disponível em: <http://www2.inca.gov.br/wps/wcm/connect/0129ba0041fbbc01aa4fee936e134226/Apresentacao+Estimativa+2014_final+corrigido+tireoide.pdf?MOD=AJPERES&CACHEID=0129ba0041fbbc01aa4fee936e134226>. [20.07.2014].
Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ. Complications of radiation therapy for head and neck cancers: the patient’s perspective. Cancer Nurs. 2002; 25(6): 461-7; quiz 468 9.
Rubira CMF, Devides NJ, Úbeda LT, Bortowcci JR AG, Lauris JR, Rubira-Bullen IRFR, Damante JR. Evaluation of some oral postradiotherapy sequelae in patients treated for head and neck tumors. Braz. oral res. 2007; 21: 272-277.
Volpato LER, Silva TC, Oliveira TM, Sakai VT, Machado MAAM. Mucosite bucal rádio e quimioinduzida. Rev. Bras. Otorrinolaringol. 2007; 73(4): 562-68.
Martins ACM, Caçador NP, Gaeti WP. Complicações bucais da quimioterapia antineoplásica. Acta Scientiarum 2002; 24(3): 663-670.
Biron P, Sebban C, Gourmet R, Chvetzoff G, Philip I, Blay JY. Research controversies in management of oral mucositis. Supp. Care Cancer 2000; 8: 68-71.
Hespanhol FL, Tinoco BEM, Teixeira HGC, Falabella MEV, Assis NMSP. Manifestações bucais em pacientes submetidos à quimioterapia. Ciênc. saúde coletiva 2010; 15(Supl.1): 1085-1094.
Santos PSS, Messaggi AC, Mantesso A, Magalhães MCG. Mucosite oral: perspectivas atuais na prevenção e tratamento. RGO 2009; 57(3): 339-344.
Coracin FL et al. Oral health as a predictive factor for oral mucositis. Clinics 2013; (6):792-796.
Silverman SJR. Diagnosis and management of oral mucositis. J Support Oncol 2007; 5(2): 13-21.
Ribeiro Júnior O, Borba AM, Guimarães Júnior J. Prevenção e tratamento da mucosite bucal: o papel fundamental do cirurgião-dentista – Revisão. Rev. Clín. Pesq. Odontol 2010; 6(1): 57-62.
Nicolatou-Galitis O, Velegraki A, Sotiropoulou-Lontou A, Dardoufas K, Kouloulias V, Kyprianou K, Kolitsi G, Skarleas C, Pissakas G, Papanicolaou VS, Kouvaris J. Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. Supp. Care Cancer 2006; 14:44-51.
Lino, MDMC, Carvalho FB, Oliveira LR, Magalhães EB, Pinheiro ALB, Ramalho LMP. Laser phototherapy as a treatment for radiotherapy-induced oral mucositis. Braz. Dent. J. 2011; 22(2): 162-165.
Markiewicz M, Dzierzak-Mietla M, Frankiewicz A, Zielinska P, Koclega A, Kruszelnicka M, Kyrcz-Krzemien S. Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation. Supp. Care Cancer 2012; 20(9): 2223-2229.
Guimarães-Júnior J. Tratamento das manifestações estomatológicas antes, no decorrer e depois da químio e radioterapia. In: Marcucci G.. Fundamentos de Odontologia: estomatologia. Rio de Janeiro: Guanabara Koogan; 2012. p. 205-12.
Oton-Leite AF, Elias LSA, Morais MO, Pinezi JCD, Leles CR, Silva MAGS, Mendonça EF. Effect of low level laser therapy in the reduction of oral complications in patients with cancer of the head and neck submitted to radiotherapy. Spec Care Dent 2013; 33(6): 294-300.
Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Vadhiraja BM. Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patients – a triple blinded randomized controlled trial. Radiotherapy & Oncology 2012; 104: 349-354.
Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Vadhiraja BM. Low level helium neon laser therapy for chemoradiotherapy induced oral mucositis in oral cancer patients – A randomized controlled trial. Oral Oncol 2012; 48: 89-897.
Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Nigudgi S. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy--a randomized controlled trial. Supp. Care Cancer 2012; 21(5): 1421-1428.
Carvalho PAG, Jaguar GC, Pellizzon AC, Prado JD, Lopes RN, Alves FA. Evaluation of low-level laser therapy in the prevention and treatment of radiation-induced mucositis: a double-blind randomized study in head and neck cancer patients. Oral Oncol 2011; 47: 1176-1181.
Antunes HS, Herchenhorn D, Small IA, Araújo CMM, Viégas CMP, Cabral E, Rampini MP, Rodrigues PC, Silva TGP, Ferreira EMS, Dias FL, Ferreira CG. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. Radiotherapy & Oncology 2013; 109: 297-302.
Lima AG, Antequera R, Peres MPSM, Snitcosky IML, Federico MHH, Villar RC. Efficacy of low-level laser therapy and aluminum hydroxide in patients with chemotherapy and radiotherapy-induced oral mucositis. Braz. Dent. J. 2010; 1(3): 186-192.
Bjordal JM, Bensadoun RJ, Tunèr J, Frigo L, Gjerde K, Martins RABL. A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Supp. Care Cancer 2011; 19(8): 1069-1077.
Vladimirov YA, Osipov AN, Klebanov GI. Photobiological principles of therapeutic applications of laser radiation. Biochemistry (Mosc) 2004; 69: 81-89.
Maluf AP, Ughini GC, Maluf RP, Pagnoncelli RM. Utilização de laser terapêutico em exodontia de terceiros molares inferiores. RGO 2006; 54: 182-184.
Karu T. Photobiology of lower laser effects. Health Phys 1989; 56(5): 691704.
Lins RDAU, Dantas EM, Lucena KCR, Granville-Garcia AF, Silva JSP. Aplicação do laser de baixa potência na cicatrização de feridas. Odontol. Clín.-Cient 2011; Suppl: 511-516.
Khanal B, Baliga M, Uppal N. Effect of topical honey on limitation of radiationinduced oral mucositis: an intervention study. Int J Oral Max Surg 2010; 39: 1181-1185.
Lis-Balchin M, Hart SL, Deans SG. Pharmacological and antimicrobial studies on different tea-tree oils (melaleuca alternifolia, leptospermum scoparium or manuka and kunzea ericoides or kanuka), originating in Australia and New Zealand. Phytother Res 2000; 14: 623-629.
Douglas M, Van Klink J, Smallfield B, Perry N, Anderson R, Johnstone P, Weavers R, Essential oils of manuka: triketone & other chemotypes of Leptospermum scoparium. Phytochemistry 2004; 65: 1255-1264.
Parsons E, Begley A, Hers P. Manuka honey mouthwash does not affect oral mucositis in head and neck cancer patients in New Zealand. J Radiother Pract 2012; 11:
-256.
Bardy J, Molassiotis A, Ryder WD, Mais K, Sykes A, Yap B, Lee L, Kaczmarski E, Slevin N. A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis. Brit J Oral Max Surg 2012; 50: 221-226.
Song JJ, Twumasi-Ankrah P, Salcido R. Systematic review and meta-analysis on the use of honey to protect from the effects of radiation-induced oral mucositis. Adv Skin Wound Care 2012; 25(1): 23-8.
National Cancer Institute. Disponível em: <http://www.cancer.gov/cancertopics/druginfo/fda-palifermin>. [11.02.2015].
Le QT, Kim HE, Schneider CJ, Murakozy G, Skladowski K, Reinisch S, Chen Y, Hickey M, Mo M, Chen MG, Berger D, Lizambri R, Henke M. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebocontrolled study. J Clin Oncol 2011; 29(20): 2808-2814.
Henke M, Alfonsi M, Giralt PF, Bardet,JE, Cerezo L, Salzwimmer M, Lizambri R, Lara Emmerson, Chen MG, Berger D. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial. J Clin Oncol 2011; 29(20): 2815-2820.
Wu SX, Cui T, Zhao C, Pan JJ, Xu BY, Tian Y, Cui NJ. A prospective, randomized, multi-center trial to investigate actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma. Radiother Oncol 2010; 97: 113-118.
Babaee N, Moslemi D, Khalilpour M, Vejdani F, Moghadamnia Y, Bijani A, Baradaran M, Kazemi
MT, Khalilpour A, Pouramir M, Moghadamnia AA. Antioxidant capacity of calendula officinalis flowers extract and prevention of radiation induced oropharyngeal mucositis in patients with head and neck cancers: a randomized controlled clinical study. DARU Journal of Pharmaceutical Sciences 2013; 21(1):18.
Bjarnason GA, Mackenzie RG, Nabid A, Hodson ID, El-Sayed S, Grimard L, Brundage M, Wright J, Hay J, Ganguly P, Leong C, Wilson J, Jordan RCK, Walker M, Tu D, Parulekar W. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the national cancer institute of Canada clinical trials group (HN3). Int J Radiat Oncol Biol Phys 2009; 73(1): 166-172.
Kakoei S, Ghassemi A, Nakhaee N. Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy. Int J Radiat Res 2013; 11(2): 117-120.
Wu HG, Song,SY, Kim YS, Oh YT, Lee CG, Keum KC, Ahn YC, Lee S. Therapeutic effect of recombinant human epidermal growth factor (rhegf) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer a double-blind placebocontrolled prospective phase 2 multi-institutional clinical trial. Cancer 2009; 3699-3708.
Puataweepong P, Dhanachai M, Dangprasert S, Sithatani C, Sawangsilp T, Narkwong L, Puttikaran P,
Intragumtornchai T. The efficacy of oral aloe vera juice for radiation induced mucositis in head and neck cancer patients: a double-blind placebo-controlled study. Asian Biomed 2009; 3(4): 375-382.
Sharma A, Rath GK, Chaudhary SP, Thakar A, Mohanti BK, Bahadur S. Lactobacillus brevis CD2 lozenges reduce radiationand chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled study. Eur J Cancer 2012; 48: 875-881.
Nomura M, Kamata M, Kojima H, Hayashi K, Sawada S. Irsogladine maleate reduces the incidence of fluorouracilbased chemotherapy-induced oral mucositis. Ann Oncol 2013; 24: 1062-1066.
Yen SH, Wang LW Lin YH, Jen YM, Chung YL. Phenylbutyrate mouthwash mitigates oral mucositis
during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2012; 82(4): 1463-1470.
Lanzós I, Herrera D, Santos S, O´Connor A, Peña C, Lanzós E, Sanz M. Mucositis in irradiated cancer patients: Effects of an antiseptic mouthrinse. Med Oral Patol Oral Cir Bucal 2010; 15(5): 732-738.
